Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about DIABETIC RETINOPATHY: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
DIABETIC RETINOPATHY is a concept in neurodegeneration research. Key relationships include: therapeutic target, associated with, activates. Associated with Aging, Als, Atherosclerosis. Connected to 204 entities in the SciDEX knowledge graph.
No AI portrait yet
| Name | DIABETIC RETINOPATHY |
| Key Genes/Proteins | AGING, AKT, ALZHEIMER, ALZHEIMER'S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, AND |
| Related Diseases | Aging, Als, ALS, Alzheimer, Amyotrophic Lateral Sclerosis |
| Related Pathways | Angiogenesis, Apoptosis |
Knowledge base pages for this entity
graph TD
DIABETIC_RETINOPATHY["DIABETIC RETINOPATHY"]
DIABETIC_RETINOPATHY -->|"causes"| NEURODEGENERATION["NEURODEGENERATION"]
DIABETIC_RETINOPATHY -->|"target for"| Neuropathy["Neuropathy"]
DIABETIC_RETINOPATHY -->|"target for"| Als["Als"]
DIABETIC_RETINOPATHY -->|"target for"| Cancer["Cancer"]
DIABETIC_RETINOPATHY -->|"target for"| Ms["Ms"]
DIABETIC_RETINOPATHY -.protects against.-> Inflammation["Inflammation"]
DIABETIC_RETINOPATHY -.protects against.-> Diabetes["Diabetes"]
DIABETIC_RETINOPATHY -.protects against.-> Neurodegeneration["Neurodegeneration"]
DIABETIC_RETINOPATHY -.protects against.-> Neuroinflammation["Neuroinflammation"]
DIABETES_MELLITUS["DIABETES MELLITUS"] -->|"causes"| DIABETIC_RETINOPATHY
NF__B_pathway["NF-kappaB pathway"] -->|"activates"| DIABETIC_RETINOPATHY
miRNA["miRNA"] -->|"regulates"| DIABETIC_RETINOPATHY
JAK["JAK"] -->|"target for"| DIABETIC_RETINOPATHY
VEGF["VEGF"] -->|"target for"| DIABETIC_RETINOPATHY
HSP90AA1["HSP90AA1"] -->|"target for"| DIABETIC_RETINOPATHY
CANCER["CANCER"] -->|"target for"| DIABETIC_RETINOPATHY
APOPTOSIS["APOPTOSIS"] -->|"target for"| DIABETIC_RETINOPATHY
BCL2["BCL2"] -->|"target for"| DIABETIC_RETINOPATHY
NF_KB["NF-KB"] -->|"target for"| DIABETIC_RETINOPATHY| Target | Relation | Type | Str |
|---|---|---|---|
| Retinopathy | therapeutic_target | disease | 1.00 |
| Als | therapeutic_target | disease | 0.95 |
| retinal ganglion cells | causes | cell_type | 0.95 |
| WIF1 | downregulates | protein | 0.90 |
| NEURODEGENERATION | causes | gene | 0.90 |
| Retinopathy | associated_with | disease | 0.85 |
| Diabetes | associated_with | disease | 0.85 |
| Diabetes | causes | disease | 0.85 |
| Retinal Neurodegeneration | causes | phenotype | 0.85 |
| Retinal Barrier Breakdown | causes | phenotype | 0.85 |
| Diabetes | activates | disease | 0.85 |
| Retinal Microvascular Deterioration | causes | phenotype | 0.85 |
| Inflammation | therapeutic_target | disease | 0.75 |
| Als | associated_with | disease | 0.75 |
| Retinopathy | activates | disease | 0.75 |
| Neurodegeneration | protects_against | disease | 0.75 |
| Senescence | therapeutic_target | disease | 0.75 |
| Diabetes | therapeutic_target | disease | 0.75 |
| Als | interacts_with | disease | 0.75 |
| Retinopathy | causes | disease | 0.75 |
| Apoptosis | activates | pathway | 0.70 |
| Apoptosis | therapeutic_target | pathway | 0.70 |
| Mitochondrial Function | therapeutic_target | pathway | 0.70 |
| Als | protects_against | disease | 0.65 |
| Cardiovascular | interacts_with | disease | 0.65 |
| Stroke | interacts_with | disease | 0.65 |
| Dementia | interacts_with | disease | 0.65 |
| Tumor | contributes_to | disease | 0.65 |
| Neuroinflammation | protects_against | disease | 0.65 |
| Inflammation | protects_against | disease | 0.65 |
| Diabetes | protects_against | disease | 0.65 |
| Macular Degeneration | associated_with | disease | 0.65 |
| Glaucoma | associated_with | disease | 0.65 |
| Osteoporosis | activates | disease | 0.65 |
| Atherosclerosis | activates | disease | 0.65 |
| Nephropathy | associated_with | disease | 0.65 |
| Tumor | therapeutic_target | disease | 0.65 |
| Ischemia | treats | disease | 0.65 |
| Hypertension | biomarker_for | disease | 0.65 |
| Retinopathy | biomarker_for | disease | 0.65 |
| Ischemia | biomarker_for | disease | 0.65 |
| Diabetes | biomarker_for | disease | 0.65 |
| Aging | interacts_with | disease | 0.65 |
| Senescence | interacts_with | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Hypertension | associated_with | disease | 0.65 |
| Atherosclerosis | associated_with | disease | 0.65 |
| Stroke | associated_with | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| DIABETES MELLITUS | causes | gene | 1.00 |
| VEGFA | involved_in | gene | 0.95 |
| VEGFA | therapeutic_target | gene | 0.95 |
| Type 2 Diabetes Mellitus | causes | disease | 0.95 |
| 5'tiRNA-His-GTG | biomarker_for | biomarker | 0.95 |
| Diabetes | causes | disease | 0.95 |
| FTO | contributes_to | protein | 0.90 |
| Downregulation Of 5'tiRNA-His-GTG | protects_against | mechanism | 0.90 |
| HDAC3 | involved_in | gene | 0.90 |
| Neuroinflammation | contributes_to | process | 0.88 |
| WIF1 | treats | protein | 0.85 |
| Microvascular Anomalies | contributes_to | phenotype | 0.85 |
| Anti-Vascular Endothelial Growth Factor Therapies | treats | drug | 0.85 |
| WIF1 | protects_against | protein | 0.85 |
| BCL2 | biomarker_for | gene | 0.80 |
| DAAO | associated_with | gene | 0.80 |
| miR-195 | promotes | gene | 0.80 |
| Targeting 5'Tirna-His-Gtg | treats | mechanism | 0.80 |
| VDR | therapeutic_target | gene | 0.80 |
| NPY | implicated_in | gene | 0.80 |
| BCL2 | protects_against | protein | 0.75 |
| plasma proteins | contributes_to | protein | 0.75 |
| NEURODEGENERATION | protects_against | gene | 0.70 |
| VEGF | protects_against | gene | 0.70 |
| NF-κB pathway | activates | pathway | 0.70 |
| DIABETES MELLITUS | associated_with | gene | 0.70 |
| miRNA | regulates | protein | 0.70 |
| oxidative stress | associated_with | process | 0.70 |
| MITOCHONDRIA | therapeutic_target | gene | 0.70 |
| APOPTOSIS | activates | gene | 0.70 |
| INFLAMMATION | therapeutic_target | gene | 0.70 |
| SRR | associated_with | gene | 0.70 |
| APOPTOSIS | therapeutic_target | gene | 0.70 |
| VEGF | therapeutic_target | gene | 0.70 |
| HSP90AA1 | therapeutic_target | gene | 0.60 |
| CANCER | therapeutic_target | gene | 0.60 |
| PI3K | associated_with | gene | 0.60 |
| FN1 | interacts_with | gene | 0.60 |
| GENES | interacts_with | gene | 0.60 |
| C-JUN | activates | gene | 0.60 |
| FOS | activates | gene | 0.60 |
| SIRT1 | activates | gene | 0.60 |
| C-FOS | activates | gene | 0.60 |
| GPX4 | regulates | gene | 0.60 |
| OXIDATIVE STRESS | expressed_in | gene | 0.60 |
| AND | expressed_in | gene | 0.60 |
| NEURODEGENERATION | associated_with | gene | 0.60 |
| ROS | expressed_in | gene | 0.60 |
| CD4 | associated_with | gene | 0.60 |
| BCL2 | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning DIABETIC RETINOPATHY in their description or question text
No additional research found